Pediatric oncology
Executive Summary
A joint session of the pediatric subcommittees of the Anti-Infective Drugs and Oncologic Drugs Advisory Committees will meet Sept. 12 to consider approaches and processes used in pediatric oncology for the development of drugs to treat serious and life-threatening diseases with limited patient populations. The meeting will begin at 8 a.m. at the Hyatt Regency in Bethesda, Md